Navigation Links
Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
Date:10/21/2009

bility to obtain regulatory approval for its product candidates include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2009 and the quarterly report on Form 10-Q for the quarter ended July 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

    Contacts:
    GendeLLindheim BioCom Partners
    Investors                                Media
    info@peregrineinc.com                    Barbara Lindheim
    (800) 987-8256                           (212) 918-4650

SOURCE Peregrine Pharmaceuticals, Inc.


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
2. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
3. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
4. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
5. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
6. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
7. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
8. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
9. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
10. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... OTTAWA , May 22, 2015 /CNW/ - More than ... prescribed to treat morning sickness in expectant mothers. Tragically, Thalidomide ... children and families. Support has been provided ... the Government of Canada in 1991 ... the absence of a legal obligation to provide support, we ...
(Date:5/22/2015)... May 22, 2015 Electrophysiologist Kevin Makati, ... traveled to Boston, MA ... 2015 Heart Rhythm Society conference. These scientific sessions ... on the ideas, people and technology that propel ... a hybrid, minimally invasive cardiac operation that combines ...
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... May 27, 2011 CVS Caremark Corporation (NYSE: ... awarded a three-year contract to provide integrated pharmacy benefit ... Service Benefit Plan, also known as the Federal Employee ... Company will continue to provide FEP,s clinical programs and ...
... Kluwer Health today announced that it has completed the ... information and clinical content for pharmacists, clinicians and hospitals ... of strategic acquisitions Wolters Kluwer Health has made in ... strong focus on the point-of-care market. ...
Cached Medicine Technology:CVS Caremark Awarded Integrated 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 2Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc. 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 Many ... added to TheCelebrityDresses.com's formal dress collections recently. Now, ... newly designed dresses, up to 70% off. The ... the world to save hundreds of dollars on ... well-known brand in red carpet fashion special occasion ...
(Date:5/26/2015)... 26, 2015 Pacifica Graduate ... the Memorial Day weekend, celebrating the outstanding accomplishments ... Pacifica’s picturesque Ladera Lane campus, located in the ... alumni traveled to Santa Barbara from all over ... , The 2015 commencement ceremonies featured the ...
(Date:5/26/2015)... Marietta, GA (PRWEB) May 26, 2015 ... Dental Associates are at it again, helping local rescue ... 25, 2015. Local dentists, Kirk Kimmerling DDS, Suzanna ... with veterinarian, Julian Peckich DVM donating 100% of proceeds ... expected to fill the parking lot to help save ...
(Date:5/25/2015)... SAN FRANCISCO (PRWEB) May 26, 2015 According ... people has retinitis pigmentosa , a degenerative eye disease. ... every 150,000 people has paroxysmal kinesigenic dyskinesia , a ... For author Joseph K. Chan , these two diseases ... Chan invites readers to walk in his shoes with his ...
(Date:5/25/2015)... 26, 2015 The National ... Dr. Heather Stanley-Christian as a 2015-2016 inductee ... She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more ... chapters. , "I'm pleased to welcome Heather into ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Joseph K. Chan Finds Faith from Disability in New Autobiography 2Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2
... study, vertical work-stations, incorporating a treadmill, could help obese employees shed ... ,The vertical walk and work desk allows people to work at ... of their own choosing. ,Designed by the authors, the ... the alphabet H and held by four locking rubber wheels, so ...
... According to researchers from the United States, anxiety appears to increase ... coronary artery disease. ,Coronary artery disease is caused ... supply oxygen and blood to the heart. This causes them ... to heart attack, angina (chest pain) and other serious complications. ...
... has found a solution for the embarrassing problem of bad ... a mouth paste that can tackle separate causes of smelly ... such as dihydrogen sulphide, which can lead to bad breath, ... has an enzyme that fights starch and cellulose in between ...
... less likely to receive several types of routine outpatient ... , according to a RAND Corporation study issued today. ... less frequently receive expensive medical care such as angioplasty ... in managed care settings. ,All the patients ...
... that polyphenols, dietary substances from vegetables, fruits and green ... by increasing the fatty acid breakdown and influence ... stimulate energy-sensing regulatory protein SIRT1. ,Polyphenols are ... and vegetables. Due to their possible health effect, polyphenols ...
... smokeless cannabis-vaporizing device delivers the same level of active ... smoking cannabis , but without the harmful toxins, according ... study, which focuses on delivery of the active ingredient ... of the journal "Clinical Pharmacology and Therapeutics." ...
Cached Medicine News:Health News:walk and Work Desk Could Help Obese Workers to Shed Weight 2Health News:Dont Worry- Be Good To Your Heart 2Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 2Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 3Health News:Intake of Polyphenol Speeds Up Fatty Acid Catabolism 2Health News:Smokeless Cannabis Delivery Device Found Efficient and Less Toxic 2
... been providing excellence in Ambulatory ECG ... of physicians in the diagnosis and ... conditions each year. State-of-the-art equipment and ... the highest standard of customer service ...
... CardioNet has developed a new, ... which allows heartbeat-by-heartbeat, ECG monitoring, analysis ... 24/7/365. Our service is initially focused ... patients with arrhythmia. Time is of ...
... The THERMOstar is a high performance ... 4 microplates. Temperature, shaking speed and incubation ... while the status parameters are displayed on ... plates above and below the microplates provide ...
... The iEMS Incubator/Shaker HT ... Thus, the iEMS Incubator/Shaker HT ... as DNA hybridization and primer ... is available as a one-cabinet ...
Medicine Products: